The needle-free diabetes treatment industry is changing due to diabetes management changes. This novel strategy aims to reduce the discomfort of standard insulin delivery procedures for patients.
Non-harmful technologies are becoming more popular. Inhalable insulin and skin patches may replace needle-based injections, making diabetes life easier emotionally and physically. The reason for this change was to meet the growing need for diabetes treatments that are less invasive and easier to use.
Insulin that you breathe in is the most popular needle-free way to treat diabetes. Inhalable insulin delivery devices are more dependable and efficient now that technology has improved. This trend makes self-administration of insulin easier and helps diabetics regulate their blood sugar.
Transdermal patches are another exciting needle-free diabetic therapy. If you put these patches to your skin, the epidermis will release insulin, eliminating the need for injections. For more accurate and consistent insulin administration, patch technologies are being developed. It will provide patients a more private and pleasant choice.
Market trends indicate that needle-free diabetes management devices are becoming more patient-centered and easier to use. Medical gadget manufacturers spend a lot on ergonomic and user-friendly designs. This ensures that diabetics may utilize these gadgets easily in their daily lives. This focus on utility aims to improve patient satisfaction and collaboration.
As more people learn about needle-free diabetes treatments, patients and doctors are accepting them. Awareness and education campaigns are essential to dispelling many myths regarding these new technology. This will make people use these technologies more.
Intelligent technology in needle-free diabetes treatment options is exciting. Insulin pens, pumps, and patches with connection and data monitoring tools provide real-time glucose monitoring. Track your glucose levels with these. This approach is growing increasingly popular as healthcare becomes more personalized and data-driven.
The needle-free diabetes treatment business is growing in developing countries. This is because more people are acquiring diabetes and middle-class people can afford better health care. Due to this trend, diabetes care is changing worldwide to provide more people new treatment options.
Legislation and treatment standardization are transforming needle-free diabetes care. Governments and other governing agencies are collaborating with corporations to establish laws for these new technologies to assure safety and efficacy. Each form of aid makes industry growth easier.
Pharmaceutical, technology, and healthcare companies are partnering more as the needle-free diabetes treatment market grows. These collaborations aim to harness the best features of each industry to speed up discovery, improve product development, and improve needle-free diabetes treatment choices.
The Needle-Free Diabetes Care Market is anticipated to reach USD 22,138.64 Million by 2030 at 8.6% CAGR during the forecast period 2022-2030. This is because of the growing diabetes population across the globe. People are looking for needle-free options for the intake of insulin.
Diabetes may be termed as a group of metabolic disorders, caused due to insulin deficiency. Needle-free medication is growing popular because it is a modern option to administer pain-free insulin medication to the patient. The diabetic population is multiplying around the world, which is expected to drive the needle-free diabetes care market growth.
Moreover, a large share of the population is also suffering from obesity. This has led to a rise in healthcare expenditure. The government is also rendering strong support for medication facilities, which will contribute to the growth of the market. Studies show that smoking adds to the probability of having diabetes in people. Moreover, more than 60% of the global population comprises smokers. This fact is also known to increase the risk of diabetes and may fuel the growth of the needle-free healthcare market.
Covid-19 Analysis
With the rise of the Covid-19 impact, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols have affected millions of small and big business institutions alike. The needle-less diabetes healthcare market saw a slight downfall post the pandemic, due to the lockdown and physical distancing.
However, the key companies have adopted measures to sell needle-free diabetes medication online. Moreover, people are growing aware of the need for needle-less diabetes healthcare provisions. Hence, these factors are expected to boost the growth of the needle-free diabetes care market value in the years to come.
Drivers
A few factors may drive the growth of the needle-free diabetes care market share. There have been increasing cases of diabetes and obesity in the population around the globe. These cases have contributed to the hike in healthcare expenditure for the people. Moreover, the government has been rendering strong support to the development of needle-free medication for diabetes. Hence, these factors are expected to accelerate global market growth.
Opportunities
The major companies that account for the largest needle-free diabetes care market share are adopting various trends such as new product launches in the field. The advancements in technology and research are adding to its growth. Moreover, most companies are adopting R&D market trends. Hence, these factors serve as opportunities for global market growth.
Restraints
There are a few factors that may inhibit the growth of the needle-free diabetes care market. One of the most important of them is the lack of awareness among people regarding the use of needle-free healthcare. Moreover, these needle-less diabetes care products are a bit expensive. Hence, these factors may hinder market growth.
Challenges
Some factors that may challenge the key diabetes healthcare providers include the cost of needle-free products. They are quite expensive and are not affordable to the majority of the diabetic population around the globe. These needle-free care products are also not available that easily. Hence, these factors challenge the key companies of the global market.
Cumulative Growth Analysis
The needle-free diabetes care market is anticipated to grow at a high speed in the years to come. This is because of the growing diabetes population across the globe. People are looking for needle-free options for the intake of insulin.
Value Chain Analysis
People are growing aware of needle-free diabetes healthcare products. These products are growing popular because of the numerous benefits they offer, without having to hurt your skin or body. Many key companies of the market have also adopted trends such as innovations and product launches. The government is also supporting market research and development. Hence, these factors may fuel the growth of the industry in the global needle-free diabetes care market forecast.
The global needle-free diabetes care market is classified into many segments such as device types, treatment, application, and end-user. Listed below are the needle-less diabetes healthcare market segments:
Diagnostic devices
Instant glucose monitoring
Continuous glucose monitoring
Treatment devices
Insulin pen
Insulin patch
Insulin inhaler
Insulin jet injector
Insulin patch
Inhaled insulin
Oral insulin
Others
Insulin delivery
Others
Hospitals & clinics
Diagnostic centres
Others
The regional division of the needle-free diabetes care market analysis comprises North America, Europe, Asia Pacific, and the rest of the world. Among them, North America is expected to rule over the global market over the forecast period (2022 – 2030). This is because most of the obese and diabetic population in the globe belongs to the North American region.
Moreover, there are huge changes in the lifestyle of people to maintain their health. This region will be followed by Europe, with the second-largest share in the global needle-free diabetes care industry. However, the Asia Pacific region is anticipated to witness the fastest market growth rate over the forecast period. This is because the Asia Pacific comprises a large share of the diabetic population.
Competitive Landscape
The needle-free diabetes care industry is dominated by a few companies that play a vital role in the growth of the market. These healthcare companies are called the key companies of the market. They contribute to the largest share of the market profit.
The companies account for the market profits by adopting various needle-free diabetes care market trends such as joint ventures, product launches, company expansions, and procurements. They are innovative insulin medication options for diabetic patients.
Key Players
Below are the key companies that offer needle-free diabetes care in the global market, with the location of their headquarters:
Medical International Technology Inc. (US)
European Pharma Group (Netherland)
Zogenix Inc. (US)
Antares Pharma Inc. (US)
Valeritas Inc. (US)
3M Company (US)
Endo International plc. (US)
INJEX Pharma AG (Germany)
Bioject Medical Technologies Inc. (US)
Crossject SA (France)
PharmaJet (US)
PenJet Corporation (US)
Recent Developments
Echo Therapeutics has developed a needle-free diabetic tester that uses a patch instead of a needle poke. The transdermal biosensor examines the blood analytes through the skin with blood drawn from the body.
DiaMonTech launched its diabetes monitor D-Base that measures blood glucose levels by passing an infrared ray through the skin. The levels are evaluated by monitoring the temperature changes on the skin.
Portal Instruments launched its jet-injection device that injects insulin into the skin through a ‘hair-thin’ stream.
Report Overview
This report delivers all the information about the growth of the global needle-free diabetes care market size in the forecast period. It also contains different sections of the market analysis to help obtain detailed information such as opportunities, challenges, drivers, Covid-19 analysis, regional analysis, competitive landscape, and others. Moreover, all the information is collected from verified primary and secondary sources to provide the expected needle-free diabetes care market outlook by the year 2030.
Geographically
Europe
Asia-Pacific
North America
Middle East & Africa
Rest of the world
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)